These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10867781)

  • 1. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample.
    Small BJ; Fratiglioni L; Viitanen M; Winblad B; Bäckman L
    Arch Neurol; 2000 Jun; 57(6):839-44. PubMed ID: 10867781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.
    Jones S; Laukka EJ; Small BJ; Fratiglioni L; Bäckman L
    Dement Geriatr Cogn Disord; 2004; 18(3-4):233-9. PubMed ID: 15286452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mild dementia in community surveys. Is it possible to increase the accuracy of our diagnostic instruments?
    Herlitz A; Small BJ; Fratiglioni L; Almkvist O; Viitanen M; Bäckman L
    Arch Neurol; 1997 Mar; 54(3):319-24. PubMed ID: 9074402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.
    Small BJ; Viitanen M; Bäckman L
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M299-304. PubMed ID: 9310084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity.
    Tatsch MF; Bottino CM; Azevedo D; Hototian SR; Moscoso MA; Folquitto JC; Scalco AZ; Louzã MR
    Am J Geriatr Psychiatry; 2006 May; 14(5):438-45. PubMed ID: 16670248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.
    Larrieu S; Letenneur L; Orgogozo JM; Fabrigoule C; Amieva H; Le Carret N; Barberger-Gateau P; Dartigues JF
    Neurology; 2002 Nov; 59(10):1594-9. PubMed ID: 12451203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset.
    Saxton J; Lopez OL; Ratcliff G; Dulberg C; Fried LP; Carlson MC; Newman AB; Kuller L
    Neurology; 2004 Dec; 63(12):2341-7. PubMed ID: 15623697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.
    Visser PJ; Verhey FR; Scheltens P; Cruts M; Ponds RW; Van Broeckhoven CL; Jolles J
    J Neurol; 2002 Mar; 249(3):312-9. PubMed ID: 11993532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort.
    Linn RT; Wolf PA; Bachman DL; Knoefel JE; Cobb JL; Belanger AJ; Kaplan EF; D'Agostino RB
    Arch Neurol; 1995 May; 52(5):485-90. PubMed ID: 7733843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.
    Chen P; Ratcliff G; Belle SH; Cauley JA; DeKosky ST; Ganguli M
    Arch Gen Psychiatry; 2001 Sep; 58(9):853-8. PubMed ID: 11545668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis.
    Small BJ; Bäckman L
    Cortex; 2007 Oct; 43(7):826-34. PubMed ID: 17941341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
    Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
    Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.
    Reid W; Broe G; Creasey H; Grayson D; McCusker E; Bennett H; Longley W; Sulway MR
    Arch Neurol; 1996 Oct; 53(10):1056-61. PubMed ID: 8859068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.
    Ingles JL; Boulton DC; Fisk JD; Rockwood K
    Stroke; 2007 Apr; 38(4):1148-53. PubMed ID: 17322075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.